[Tree] Acquisition of Carmot Therapeutics by Roche and appointment of Heike Keilhack as Chief Scientific Officer at ROME Therapeutics

Version 0.04 (2024-01-04 14:26:59.805000)

updates: Acquisition of Carmot Therapeutics by Roche and appointment of Heike Keilhack as Chief Scientific Officer at ROME Therapeutics

  • ➔
  • ➔
Version 0.03 (2023-12-04 06:32:09.034000)

updates: Roche's acquisition of Carmot Therapeutics and its clinical stage assets

  • ➔
Version 0.02 (2023-12-04 06:06:15.737000)

updates: AbbVie's acquisition of ImmunoGen and investment in ADCs

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.01 (2023-11-20 14:59:38.396000)

updates: Integration of the surge in ADC investments

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
Version 0.0 (2023-11-14 08:04:41.189000)

updates:

  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔
  • ➔